share_log

近5万股东踩雷,千山药机财务造假正式退市

Nearly 50,000 shareholders stepped on the thunderstorm, and Qianyama Pharmaceutical Machinery was officially delisted due to financial fraud

云掌财经 ·  Jul 15, 2020 17:13

From the A-share 100-yuan club for 15 years to now facing delisting, one year after the suspension.Qianshan medicine machineFinally, it was delisted, accompanied by the delisting of Qianshan yam machine, and nearly 50,000 shareholders.

20200715175255163v246wgn6o4hof8p

Qianshan Pharmaceutical, which was delisted half a step because of poor performance in 2019, received the advance notice of Administrative punishment and Market ban from the Securities Regulatory Commission at the end of the year. The company's shares may be delisted at any time because of false records in its annual reports for two consecutive years in 2015 and 2016 and failure to perform interim reporting on related parties' non-operating occupation of company funds in 2017. According to the announcement of the Shenzhen Stock Exchange, the delisted company Shenzhen Stock Exchange will no longer accept applications for re-listing, that is, once Qianshan Yam machineGemDelisting, then it is permanent delisting.

Half a year has passed since the CSRC issued the notice, and on July 14, the Shenzhen Stock Exchange formally issued a "death sentence" to Qianshan Pharmaceutical Machine, and the listing of Qianshan Pharmaceutical shares was terminated.

20200715175255737v246dnudq4u3c2i

Qianshan Pharmaceutical, founded in 2002, acquired and reorganized its assets after landing in A shares in 2011, while carrying "genetic testing".Accurate medical treatment"and other concepts, the market capitalization once reached 30 billion, but sitting on a number of patented scientific and technological achievements, the main business has not made any money, and frequent investment has not been able to achieve the expected return. In addition, because of the sharp decline in the performance of Honghao Gene, which was acquired in the early years, its revenue from 54.81 million in 2016 to 10.22 million in 2017 has had a significant impact on the overall performance of Qianshan Yam. At the same time, the confusion in the management of the company is also the cause of the current situation of Qianshan Pharmaceutical Machine.

According to data from Qianshan Yam, the total number of households holding its shares is still 48184 as of May 29, which means that these shareholders have delisted along with Qianshan Yam.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment